Here, we independently confirmed high NFKBIZ expression in MyD88L265P lymphoma cells and identified NFKBIZ as one of the top genes upregulated by MyD88L265P oncogenic NF-κB signaling. The gene discussed is NFKB1; the disease is lymphoma.